Expression analysis of human Rhesus blood group antigens by gene transduction into erythroid and non-erythroid cells. 1998

S Iwamoto, and M Yamasaki, and M Kawano, and H Okuda, and T Omi, and J Takahashi, and Y Tani, and M Omine, and E Kajii
Department of Legal Medicine and Human Genetics, Jichi Medical School, Tochigi, Japan. siwamoto@ms.jichi.ac.jp

Rh blood group antigens are associated with non-glycosylated human erythrocyte membrane proteins encoded by two closely related genes, RHCE and RHD, and with a glycoprotein, a critical co-expressing factor encoded by the RH50 gene. The sequence analysis of RHCE transcripts has revealed that RhE/e and C/c serological phenotypes are associated with a nucleotide substitution in exon 5 and six substitutions in exons 1 and 2 of RHCE gene, respectively. Smythe et al. have shown that the full length transcript of RhcE gene expressed c and E antigens and the transcript of RhD gene expressed D and G antigens, using retroviral-mediated gene transduction into K562 cells. We performed an epitope analysis of Rh antigen by constructing retroviral gene coding six RH cDNAs, which contain RhcE, ce, CE and D cDNAs, and CE-D, D-CE chimera cDNAs. The cDNAs were introduced into KU812E cells and the expressed antigens were analyzed by flow cytometry. These studies revealed that the C/c and E/e associated substitutions actually participated in respective polymorphic epitopes. However, the C antigen was not detected on the KU812E cells introduced with CE cDNA, despite E antigen being expressed. The study with the chimera gene between CE and D cDNAs also indicated that the Rh epitopes were not constructed with short polymorphic exofacial peptide loops only but also with other peptide fragments and membrane components. Co-expression studies of Rh50 and RhD or cE gene in non-erythroid cells, 293, and expression studies of Rh50 in another erythroid cell, HEL, did not show any Rh antigens on the transduced cells, despite the Northern blot study showing both transcripts in the cells. It was suggested that at least a second co-expressing factor was needed to express RhCE or D antigens on the plasma membrane.

UI MeSH Term Description Entries
D007519 Isoantigens Antigens that exist in alternative (allelic) forms in a single species. When an isoantigen is encountered by species members who lack it, an immune response is induced. Typical isoantigens are the BLOOD GROUP ANTIGENS. Alloantigens,Alloantigen,Isoantigen
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D004912 Erythrocytes Red blood cells. Mature erythrocytes are non-nucleated, biconcave disks containing HEMOGLOBIN whose function is to transport OXYGEN. Blood Cells, Red,Blood Corpuscles, Red,Red Blood Cells,Red Blood Corpuscles,Blood Cell, Red,Blood Corpuscle, Red,Erythrocyte,Red Blood Cell,Red Blood Corpuscle
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012204 Rh-Hr Blood-Group System Erythrocyte isoantigens of the Rh (Rhesus) blood group system, the most complex of all human blood groups. The major antigen Rh or D is the most common cause of erythroblastosis fetalis. Rh Factors,Rhesus Blood-Group System,Antigen D, Rh Blood Group,Blood-Group System, Rh-Hr,Blood-Group System, Rhesus,Blood-Group Systems, Rh-Hr,Blood-Group Systems, Rhesus,Factor, Rh,Factors, Rh,Rh Factor,Rh Hr Blood Group System,Rh-Hr Blood-Group Systems,Rhesus Blood Group System,Rhesus Blood-Group Systems,System, Rh-Hr Blood-Group,System, Rhesus Blood-Group,Systems, Rh-Hr Blood-Group,Systems, Rhesus Blood-Group
D014161 Transduction, Genetic The transfer of bacterial DNA by phages from an infected bacterium to another bacterium. This also refers to the transfer of genes into eukaryotic cells by viruses. This naturally occurring process is routinely employed as a GENE TRANSFER TECHNIQUE. Genetic Transduction,Genetic Transductions,Transductions, Genetic

Related Publications

S Iwamoto, and M Yamasaki, and M Kawano, and H Okuda, and T Omi, and J Takahashi, and Y Tani, and M Omine, and E Kajii
September 1985, Blood,
S Iwamoto, and M Yamasaki, and M Kawano, and H Okuda, and T Omi, and J Takahashi, and Y Tani, and M Omine, and E Kajii
April 1986, The Journal of investigative dermatology,
S Iwamoto, and M Yamasaki, and M Kawano, and H Okuda, and T Omi, and J Takahashi, and Y Tani, and M Omine, and E Kajii
November 1999, British journal of haematology,
S Iwamoto, and M Yamasaki, and M Kawano, and H Okuda, and T Omi, and J Takahashi, and Y Tani, and M Omine, and E Kajii
January 1990, Blood,
S Iwamoto, and M Yamasaki, and M Kawano, and H Okuda, and T Omi, and J Takahashi, and Y Tani, and M Omine, and E Kajii
December 1996, Bone marrow transplantation,
S Iwamoto, and M Yamasaki, and M Kawano, and H Okuda, and T Omi, and J Takahashi, and Y Tani, and M Omine, and E Kajii
July 2010, Human gene therapy,
S Iwamoto, and M Yamasaki, and M Kawano, and H Okuda, and T Omi, and J Takahashi, and Y Tani, and M Omine, and E Kajii
December 1986, The Journal of investigative dermatology,
S Iwamoto, and M Yamasaki, and M Kawano, and H Okuda, and T Omi, and J Takahashi, and Y Tani, and M Omine, and E Kajii
June 1989, The Journal of biological chemistry,
S Iwamoto, and M Yamasaki, and M Kawano, and H Okuda, and T Omi, and J Takahashi, and Y Tani, and M Omine, and E Kajii
January 1987, Acta dermato-venereologica,
S Iwamoto, and M Yamasaki, and M Kawano, and H Okuda, and T Omi, and J Takahashi, and Y Tani, and M Omine, and E Kajii
January 2001, Journal of immunotherapy (Hagerstown, Md. : 1997),
Copied contents to your clipboard!